期刊文献+

莫达非尼片在健康人体的药代动力学研究 被引量:1

Pharmacokinetic Study of Modafinil Tablets in Healthy Volunteers
下载PDF
导出
摘要 目的在中国健康男性志愿者中进行莫达非尼片的药动学研究。方法30名男性健康志愿者随机分为3个剂量组:单次口服给药低、中、高剂量(100,200,400 mg)组;多次口服给药组,每天给药1次,每次200 mg,连续给药7 d。采用高效液相色谱法(HPLC)测定血浆中莫达非尼浓度。应用DAS2.0软件进行数据处理,求算药动学参数。结果莫达非尼片单次口服给药低、中、高剂量组主要药动学参数AUC0-t分别为(33.49±9.31),(82.52±20.88),(173.72±38.60)mg·h/L;AUC0-∞分别为(36.05±10.51),(87.70±24.42),(189.33±53.81)mg·h/L;Cmax分别为(2.44±0.35),(5.45±0.93),(9.90±1.13)mg/L;tmax分别为(2.35±0.85),(2.35±1.00),(2.70±0.89)h;t1/2分别为(14.08±3.31),(14.52±2.48),(15.99±3.59)h;多次口服给药组主要药动学参数分别为:AUCss为(88.60±28.84)mg·h/L;AUC0-t为(124.80±48.71)mg·h/L;AUC0-∞为(136.53±60.80)mg·h/L;Css_max为(6.99±1.68)mg/L;Css_min为(1.98±1.02)mg/L;tmax为(1.95±0.96)h;t1/2为(16.26±3.03)h。单次口服给药3个剂量药动学参数AUC0-∞,Cmax,t1/2z,CLz,Vz经方差分析后组间差异无统计意义(P>0.05);多次口服给药达稳态时的AUC0-t,AUC0-∞与单次给药相比有所升高,差异具有统计学意义(P<0.05)。结论单次口服莫达非尼片在中国健康男性受试者体内的代谢规律符合线性药动学特征。 Objective To study the pharmacokinetic profile of Modafinil Tablets in Chinese healthy male volunteers.Methods 30 healthy male volunteers were divided randomly into low,medium and high dose groups,in which the volunteers received a single dose of 100,200 or 400 mg of Modafinil Tablets orally,respectively.The volunteers who received 200 mg of Modafinil Tablets once then received Modafinil Tablets for 7 consecutive days,200 mg once daily.The plasma concentration of Modafinil was determined by HPLC,and the pharmacokinetic parameters were calculated by DAS 2.0 software.Results The main pharmacokinetic parameters of a single oral dose of 100,200 and 400 mg of Modafinil Tablets were as follows:AUC0-t:(33.49±9.31),(82.52±20.88),(173.72±38.60)mg·h/L;AUC0-∞:(36.05±10.51),(87.70±24.42),(189.33±53.81)mg·h/L;Cmax:(2.44±0.35),(5.45±0.93),(9.90±1.13)mg/L;tmax:(2.35±0.85),(2.35±1.00),(2.70±0.89)h;t1/2:(14.08±3.31),(14.52±2.48),(15.99±3.59)h.The main pharmacokinetic parameters of multiple oral doses of Modafinil Tablets were as follows:AUCss:(88.60±28.84)mg·h/L;AUC0-t:(124.80±48.71)mg·h/L;AUC0-∞:(136.53±60.80)mg·h/L;Css_max:(6.99±1.68)mg/L;Css_min:(1.98±1.02)mg/L;tmax:(1.95±0.96)h;t1/2:(16.26±3.03)h.There were no significant difference between AUC0-∞,Cmax,t1/2z,CLz,Vz of different single dose of Modafinil Tablets(P>0.05).AUC0-t and AUC0-∞increased after repeated administration(P<0.05).Conclusion The metabolism of Modafinil in Chinese healthy male subjects is in line with the linear pharmacokinetic characteristics.
作者 黄露 苏琼 郭源源 HUANG Lu;SU Qiong;GUO Yuan-yuan(Liyuan Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China)
出处 《食品与药品》 CAS 2020年第2期115-120,共6页 Food and Drug
关键词 莫达非尼片 药动学 高效液相色谱 Modafinil Tablets pharmacokinetics HPLC
  • 相关文献

参考文献5

二级参考文献84

  • 1穆报春,李丽琴,李云祥,雷光清.莫达非尼的研究进展[J].中国新药杂志,2004,13(9):789-792. 被引量:4
  • 2王睿,方翼,周筱青,柴栋,王中孝,王林,金义光,彭涛.单次口服莫达芬尼片在中国健康志愿者的药代动力学[J].中国临床药理学杂志,2004,20(4):278-282. 被引量:8
  • 3张琳,赵忠新.中枢兴奋剂莫达非尼对认知功能的影响及可能机制[J].中国新药与临床杂志,2007,26(1):71-75. 被引量:3
  • 4钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 5WONG Y N, KING S P, LAUGHTON W B, et al. Single-dose pharmacokinetics of modafinil and methylphanidate given alone or in combination in healthy male volunteers[J]. J Clin Pharmacol, 1998,38(3): 276-282.
  • 6国家食品药品监督管理局.化学药物非临床药代动力学研究技术指导原则.2005-03-18.
  • 7佚名.神经系统用药[S]//国家药典委员会.中华人民共和国药典临床用药须知:化学药和生物制品卷.2010年版,北京:中国医药科技出版社,2010:1-107.
  • 8PIGEAU R,NAITOH P,BUGUET A,et al.Modafinil,d-am-phetamine and placebo during 64 hours of sustained mental work.I.Effects on mood,fatigue,cognitive performance and body tem-perature[J].J Sleep Res,1995,4(4):212-228.
  • 9WESENSTEN NJ,BELENKY G,KAUTZ MA,et al.Maintain-ing alertness and performance during sleep deprivation:modafinilversus caffeine[J].Psychopharmacology(Berl),2002,159(3):238-247.
  • 10BENSIMON G,BENOIT D,LACOMBLEZ L,et al.Antagonismby modafinil of the psychomotor and cognitive impairmentinduced by sleep-deprivation in 12 healthy volunteers[J].EurPsychiatry,1991,6(2):93-97.

共引文献15

同被引文献6

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部